Weld Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,518
Closed -$349K 595
2020
Q2
$349K Buy
+2,518
New +$231K 0.14% 243
2020
Q1
Sell
-19,455
Closed -$2.13M 595
2019
Q4
$2.13M Buy
19,455
+17,339
+819% +$1.68M 0.41% 50
2019
Q3
$219K Sell
2,116
-15,942
-88% -$1.71M 0.04% 673
2019
Q2
$2.32M Sell
18,058
-609
-3% -$84.6K 0.43% 29
2019
Q1
$2.38M Buy
18,667
+6,198
+50% +$786K 0.43% 27
2018
Q4
$1.56M Buy
+12,469
New +$2.13M 0.35% 51

Other funds holding MED

Weld Capital Management's MED Position: Q3 2020 in Review

Weld Capital Management sold out of Medifast (MED) in Q3 2020, closing a stake of 2,518 shares — an estimated $349K sold.

Weld Capital Management first reported a position in MED in Q4 2018 and held it in 6 quarters. The position peaked at $2.38M in Q1 2019. 240 funds tracked by Wall St. Rank hold MED as of Q3 2020.

  • Weld Capital Management reported no remaining Medifast position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 2,518 Medifast shares in Q3 2020, an estimated $349K.
  • Weld Capital Management first reported a position in Medifast in Q4 2018 and held it in 6 quarters.
  • Weld Capital Management's Medifast position peaked at $2.38M in Q1 2019.
  • 240 funds tracked by Wall St. Rank held Medifast as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.